Parkman Healthcare Partners’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,221
| Closed | -$267K | – | 83 |
|
|
2022
Q3 | $267K | Buy |
7,221
+85
| +1% | +$3.14K | 0.08% | 87 |
|
|
2022
Q2 | $365K | Buy |
7,136
+369
| +5% | +$18.9K | 0.13% | 72 |
|
|
2022
Q1 | $463K | Sell |
6,767
-3,948
| -37% | -$270K | 0.14% | 75 |
|
|
2021
Q4 | $874K | Buy |
10,715
+438
| +4% | +$35.7K | 0.19% | 76 |
|
|
2021
Q3 | $1.13M | Sell |
10,277
-8,074
| -44% | -$888K | 0.29% | 63 |
|
|
2021
Q2 | $2.06M | Buy |
18,351
+7,598
| +71% | +$854K | 0.45% | 55 |
|
|
2021
Q1 | $1.2M | Buy |
10,753
+54
| +0.5% | +$6.03K | 0.28% | 70 |
|
|
2020
Q4 | $1.08M | Buy |
+10,699
| New | +$1.08M | 0.28% | 75 |
|